Fluorescence-Guided Resection of Spinal Metastases of Malignant Glioma: Report of 2 Cases^[*]

Introduction

Malignant gliomas rarely metastasize outside the central nervous system.[4] Therefore, data on surgical resection and its impact on the outcome for metastatic manifestations of these entities are limited. Since the pivotal publication of Stummer et al., 5-ALA-based fluorescence-guided surgery (FGS) is well established for the resection of cerebral malignant gliomas.[3] [5] [6] [7] [8] [9] To date, there are no reports investigating the potential role of FGS for extracranial manifestations of this disease. Therefore, we report our experience with FGS for spinal epidural, intradural, and intraosseous metastases of a World Health Organization (WHO) grade IV glioblastoma and a WHO grade III anaplastic oligodendroglioma in the lumbar and thoracic spine, respectively.

^* This article was originally Published online in Central European Neurosurgery on March 10, 2011 (DOI:10.1055/s-0030-1268499)

• References

• 1 Ferreira NF, Barbosa M, Amaral LL , et al. [Magnetic resonance imaging in 67 cases of glioblastoma multiforme and occurrence of metastases]. Arquivos de Neuro-Psiquiatria 2004; 62: 695-700
• 2 Hubner F, Braun V, Richter HP. Case reports of symptomatic metastases in four patients with primary intracranial gliomas. Acta Neurochir (Wien) 2001; 143: 25-29
• 3 Pichlmeier U, Bink A, Schackert G , et al. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 2008; 10: 1025-1034
• 4 Schweitzer T, Vince GH, Herbold C , et al. Extraneural metastases of primary brain tumors. J Neuro-Oncology 2001; 53: 107-114
• 5 Stummer W, Beck T, Beyer W , et al. Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neuro-Oncology 2008; 87: 103-109
• 6 Stummer W, Novotny A, Stepp H , et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93: 1003-1013
• 7 Stummer W, Pichlmeier U, Meinel T , et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncology 2006; 7: 392-401
• 8 Stummer W, Reulen HJ, Meinel T , et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008; 62: 564-576 ; discussion 564–576
• 9 Stummer W, Reulen HJ, Novotny A , et al. Fluorescence-guided resections of malignant gliomas–an overview. Acta Neurochir 2003; 88: 9-12
• 10 Stummer W, Kamp MA. The importance of resection in malignant glioma. Current Opinion Neurology 2009; 22 (6) 645-649
• 11 Ewelt C, Stummer W, Klink B , et al. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg 2010; 112 (4) 357-361
• 12 Arai T, Tani S, Isoshima A , et al. Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note. No Shinkei Geka 2006; 34 (8) 811-817
• 13 Shimizu S, Utsuki S, Sato K , et al. Photodynamic diagnosis in surgery for spinal ependymoma. Case illustration. J Neurosurg Spine 2006; 5: 380